UroGen Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.10.24	UroGen Pharma: FDA Accepts UGN-102 NDA For Treatment Of Low-Grade Bladder Cancer (RTTNews)
09.10.24	UroGen Pharma Appoints Chris Degnan To Succeed Don Kim As CFO (RTTNews)
18.06.24	UroGen Pharma Announces Pricing Of Public Offering Of Shares And Pre-Funded Warrants (RTTNews)
13.06.24	UroGen Receives Positive Response Rate From Phase 3 Trial Of UGN-102 For Bladder Cancer; Stock Up (RTTNews)
03.04.24	UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma (RTTNews)
17.01.24	UroGen Pharma Signs With Medac To Develop Mitosin-based UGN-103 For Urothelial Cancers (RTTNews)
14.11.23	UroGen Pharma Ltd. Q3 Loss decreases, beats estimates (RTTNews)
03.10.23	UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024 (RTTNews)
10.08.23	UroGen Pharma Ltd. Q2 Loss decreases, beats estimates (RTTNews)
28.07.23	Pre-market Movers: SIGA, SNBR, BLUA, SNTG, PRZO… (RTTNews)
16.03.23	UroGen Pharma Posts Narrower Loss In Q4 (RTTNews)
11.01.23	UroGen Reports Results Of First Post-Commercial Utilization Review Of JELMYTO (RTTNews)
02.12.22	UroGen : Phase 3 Data Show JELMYTO Provides Effective & Durable Kidney-sparing Treatment Option (RTTNews)
28.09.22	UroGen Pharma Announces Label Change For JELMYTO - Quick Facts (RTTNews)
11.08.22	UroGen Pharma Ltd. Q2 Loss Rises (RTTNews)
22.03.22	CLRB To Report WM Trial Data In 2H, DICE On Watch, URGN Sees 46%-67% Revenue Growth In 2022 (RTTNews)
13.09.21	UroGen Pharma Reports Final Data From Key Trials Evaluating UGN-102 And Jelmyto (RTTNews)
02.09.20	ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again (RTTNews)
27.08.20	UroGen Pharma: Phase 2 APOLLO Clinical Trial Did Not Meet Primary Endpoint (RTTNews)
16.04.20	RCUS Abuzz, FDA Approves First Therapy For LG UTUC, VNDA Joins COVID-19 Battle (RTTNews)
21.09.19	Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV…) (RTTNews)
24.01.19	ADXS Cervical Cancer Trial Put On Hold, GIS Recalls Flour, NCNA, URGN Slump (RTTNews)
20.01.19	Trial & Error: The Changing Landscape Of Cancer (RTTNews)
19.05.18	An Ear To The Pharma: 11 Stocks To Watch (DOVA, SESN, URGN…) (RTTNews)
05.04.18	In The Spotlight: Urogen Pharma (RTTNews)
04.04.18	CASI Makes Case For Hope, MYND On Track, URGN Sprints, No Stopping INNT (RTTNews)
07.02.18	ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD (RTTNews)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
04.01.18	ARWR Hits A High, URGN Begins 2018 In Style, ARNA To Report Data In Q1 (RTTNews)
31.10.17	ADMS Draws Attention, AAAP Buyout Rumor Becomes Real, GBT Exudes HOPE (RTTNews)
25.10.17	ATOS Catches Eyes, PTIE Gains, CNCE Hits Right Notes, SMMT Keeps Sliding (RTTNews)
01.09.17	IPXL Reveals Oriental Stakeholder, LENS Has A Vision, STDY Is Very Shaky (RTTNews)
27.06.17	Gainers & Losers Of June 26: AVEO, MBRX, SELB, NEOT, SGEN... (RTTNews)
09.05.17	Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.70	2.66 %	K V
Lonza Grp	529.60	1.57 %	K V
Part Grp Hldg	1’278.50	1.19 %	K V
Nestle	76.56	0.74 %	K V
UBS Group	28.47	0.60 %	K V
Sonova Hldg	310.60	-0.48 %	K V
Swisscom	506.50	-0.59 %	K V
Zurich Insur Gr	549.00	-0.72 %	K V
Swiss Life Hldg	726.60	-0.95 %	K V
Novartis	92.60	-1.15 %	K V

Nachrichten zu UroGen Pharma Ltd Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten